- Home
- NAMS vs TCBI Comparison
NAMS vs TCBI Comparison
Compare NAMS & TCBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAMS | TCBI |
|---|---|---|
| Founded | 2019 | 1996 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAMS | TCBI |
|---|---|---|
| Price | $32.69 | $96.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 12 |
| Target Price | $47.33 | ★ $99.25 |
| AVG Volume (30 Days) | ★ 666.3K | 504.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $38.17 | $14.68 |
| Revenue Next Year | $573.62 | $7.48 |
| P/E Ratio | ★ N/A | $15.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.06 | $59.37 |
| 52 Week High | $42.00 | $108.92 |
Technical Indicators
Market Signals| Indicator | NAMS | TCBI |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 43.04 |
| Support Level | $30.34 | $90.82 |
| Resistance Level | $37.43 | $106.98 |
| Average True Range (ATR) | 1.82 | 3.72 |
| MACD | -0.12 | -1.11 |
| Stochastic Oscillator | 5.46 | 26.35 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.